SR ONE Capital Management, LLC is 10% Owner at Odyssey Therapeutics, Inc. (ODTX). They have made 6 open-market trades across 4 companies since 2024, most recently 2026-09-28.
CIK 0001853723
5 open-market purchases totalling $61.3M since 2024, against 1 sale. Across 5 scored buys the stock is down 4.9% at seven days, and 6.6 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| DSGN | 5,376,476 | $55.5M |
| ADRX | 1,953,505 | $34.3M |
| ZBIO | 1,173,395 | $29.2M |
| AVLN | 1,122,087 | $26.6M |
| ODTX | 1,014,851 | $17.5M |
| Total | $163.1M |
Shares reported on the most recent Form 4, priced at the 2026-09-29 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | — | — |
| Avg Move | -4.9% | — | — |
| Alpha | -6.6% | — | — |
| Scored | 5 | 4 | 4 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ADRX | BUY | 2026-09-28 | 2026-09-29 | $17.00 | $17.1M | -14.9% | — | — |
| ODTX | BUY | 2026-05-11 | 2026-05-11 | $18.00 | $10.0M | +2.8% | -7.3% | +28.1% |
| ODTX | SELL | 2026-05-11 | 2026-05-11 | $18.00 | $32K | +2.8% | -7.3% | +28.1% |
| AVLN | BUY | 2026-05-01 | 2026-05-01 | $18.00 | $10.0M | +2.1% | -11.6% | -3.2% |
| ZBIO | BUY | 2025-10-09 | 2025-10-14 | $19.00 | $1.2M | -10.9% | +33.0% | -26.2% |
| ZBIO | BUY | 2024-09-16 | 2024-09-16 | $17.00 | $23.0M | -3.8% | +8.4% | -51.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.